Study type

Study topic

Disease /health condition

Study type

Non-interventional study

Scope of the study

Drug utilisation

Data collection methods

Combined primary and secondary data collection
Non-interventional study

Non-interventional study design

Cross-sectional
Study drug and medical condition

Medical condition to be studied

Chronic obstructive pulmonary disease
Population studied

Short description of the study population

Chronic obstructive pulmonary disease (COPD) patients treated with or without ICS in primary care, in Spain.

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Special population of interest

Other

Special population of interest, other

Chronic obstructive pulmonary disease (COPD) patients

Estimated number of subjects

1000
Study design details

Main study objective

To describe the patient profile for patients treated with ICS at the time of study visit.

Outcomes

The primary outcome is to describe the proportion of patients currently on ICS who did not have moderate/severe exacerbation in the year prior to the study visit. Some of the secondary objectives are:- To describe the patient profile for patients not treated with ICS at the time of study visit- To assess the proportion and the number (count) of patients with COPD treated with ICS at the time of study visit with or without moderate-to-severe exacerbations, both in the previous 1 year and previous 2 years before the study visit.

Data analysis plan

The primary outcome is to describe the proportion of patients currently on ICS who did not have moderate/severe exacerbation in theyear prior to the study visit.Sub-group analysis in the group of patients treated with ICS may be considered according ICS long term use and ICS only for short courses.Since the study is descriptive, the variables included in the study objectives will be summarized overall and by factors of interest. All results will be summarized with measures of central tendency (mean and median), variability/dispersion (standard deviation and interquartile ranges), absolute and relative frequencies, and ranges.The analysis population will consist of all eligible patients (i.e. all patients fulfilling all inclusion criteria and no exclusion criteria). If patients have missing values for an outcome, those patients will be excluded for that outcome’s analysis. Missing data will not be imputed.